Regulation of spermatogonial stem cell self-renewal and spermatocyte meiosis by Sertoli cell signaling

• Published in: Reproduction (Cambridge, England) Vol. 149; no. 4; pp. R159 - R167
• Main Authors: Chen, Su-Ren, Liu, Yi-Xun
• Format: Journal Article
• Language: English
• Published: England Bioscientifica Ltd 01.04.2015
• Subjects: Humans; Male; Meiosis - physiology; Review; Sertoli Cells - cytology; Sertoli Cells - physiology; Signal Transduction; Spermatocytes - cytology; Spermatocytes - physiology; Spermatogenesis - physiology; Spermatogonia - cytology; Spermatogonia - metabolism; Stem Cells - cytology; Stem Cells - metabolism
• ISSN: 1470-1626; 1741-7899
• DOI: 10.1530/REP-14-0481

Spermatogenesis is a continuous and productive process supported by the self-renewal and differentiation of spermatogonial stem cells (SSCs), which arise from undifferentiated precursors known as gonocytes and are strictly controlled in a special ‘niche’ microenvironment in the seminiferous tubules. Sertoli cells, the only somatic cell type in the tubules, directly interact with SSCs to control their proliferation and differentiation through the secretion of specific factors. Spermatocyte meiosis is another key step of spermatogenesis, which is regulated by Sertoli cells on the luminal side of the blood–testis barrier through paracrine signaling. In this review, we mainly focus on the role of Sertoli cells in the regulation of SSC self-renewal and spermatocyte meiosis, with particular emphasis on paracrine and endocrine-mediated signaling pathways. Sertoli cell growth factors, such as glial cell line-derived neurotrophic factor (GDNF) and fibroblast growth factor 2 (FGF2), as well as Sertoli cell transcription factors, such as ETS variant 5 (ERM; also known as ETV5), nociceptin, neuregulin 1 (NRG1), and androgen receptor (AR), have been identified as the most important upstream factors that regulate SSC self-renewal and spermatocyte meiosis. Other transcription factors and signaling pathways (GDNF–RET–GFRA1 signaling, FGF2–MAP2K1 signaling, CXCL12–CXCR4 signaling, CCL9–CCR1 signaling, FSH–nociceptin/OPRL1, retinoic acid/FSH–NRG/ERBB4, and AR/RB–ARID4A/ARID4B) are also addressed.